Review article on Quality Control in Clinical Trials

Year : 2025 | Volume : 12 | Issue : 03 | Page : 01 07
    By

    Krishika Vinay jain,

  • Sunila A. Patil,

  • Amruta N. Patil,

  1. B. Pharm, Student, Department of Pharmaceutical Science, P. S. G. V. P. Mandal’s College of Pharmacy, shahada, Maharashtra, India
  2. B. Pharm, Student, Associate Professor, Department of Pharmaceutical Chemistry, P. S. G. V. P. Mandal’s College of Pharmacy, shahada, Maharashtra, India
  3. B. Pharm, Student, Associate Professor, Department of Pharmaceutical Chemistry, P. S. G. V. P. Mandal’s College of Pharmacy, shahada, Maharashtra, India

Abstract

Quality control (QC) is a critical component in the conduct of clinical trials, ensuring the accuracy, reliability, and credibility of data collected throughout the study. It encompasses a systematic set of procedures designed to monitor trial conduct and data integrity, thus safeguarding the rights, safety, and well-being of participants. This review explores the principles, implementation, and evolving practices of quality control in clinical trials, highlighting its importance across all phases of research. QC activities are implemented at multiple stages of a trial, beginning with protocol development and extending through data collection, data entry, monitoring, and final reporting. Key components include standard operating procedures (SOPs), staff training, site monitoring visits, data verification, audit trails, and centralized statistical monitoring. Proper QC helps ensure compliance with Good Clinical Practice (GCP) guidelines and regulatory requirements, such as those set by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). The effectiveness of quality control is increasingly supported by technological advancements, including electronic data capture (EDC) systems, risk-based monitoring, and real-time analytics. These tools allow early detection of protocol deviations, data inconsistencies, and potential fraud. Moreover, centralized monitoring approaches are gaining traction as a cost-effective complement to traditional on-site monitoring, enhancing QC efficiency without compromising data quality. Despite its significance, implementing robust QC strategies faces several challenges, such as resource constraints, variability across study sites, and the complexity of multinational trials. Addressing these challenges requires a proactive quality-by-design approach, integrating QC considerations early in trial planning and design. Collaboration among sponsors, clinical research organizations (CROs), investigators, and regulatory bodies is essential for fostering a culture of quality and continuous improvement. This review emphasizes the evolving role of quality control in ensuring scientific validity and ethical integrity in clinical trials. As regulatory expectations rise and trial designs become more complex, the demand for comprehensive, adaptive QC systems continues to grow. Future directions include greater integration of artificial intelligence, machine learning, and real-time dashboards to further enhance oversight and predictive quality metrics. Ultimately, robust quality control mechanisms are vital not only for regulatory approval but also for maintaining public trust in clinical research.

Keywords: Clinical trials, quality control,audit trials, Documentation, patient safety , regulatory compliance, quality by design.

[This article belongs to Research & Reviews: A Journal of Drug Design & Discovery ]

How to cite this article:
Krishika Vinay jain, Sunila A. Patil, Amruta N. Patil. Review article on Quality Control in Clinical Trials. Research & Reviews: A Journal of Drug Design & Discovery. 2025; 12(03):01-07.
How to cite this URL:
Krishika Vinay jain, Sunila A. Patil, Amruta N. Patil. Review article on Quality Control in Clinical Trials. Research & Reviews: A Journal of Drug Design & Discovery. 2025; 12(03):01-07. Available from: https://journals.stmjournals.com/rrjoddd/article=2025/view=224926


References

  1. Recent advances in quality management of clinical trials. Johnson J, Gupta NV. https://www.researchgate.net/publication/263657414_Recent_advances_in_quality_management
    _of_clinical_trials Int J Pharm Pharm Sci. 2013;5:34–38. [Google Scholar]
  2. Elisabeth P. compliance corporate Sanafi research, gentilly codex, France,1992, 2,189-196.
  3. Chillarege.Software testing best practices, IBM research technical report, 1999,26.
  4. Chase D, and Letzel H.. System audit of contract research organizations in Germany lat.J.pharma med. 2001,15,191-196.
  5. Patil SM, Sapkale GN, Kumbhar PB, Maske AP. Quality Assurance in clinical trial. Research Journal of Pharmacology and Pharmacodynamics. 2010;2(1):1-4.
  6. Washington DC. U.S.Depatment of healthand human services, code of federal regulation, 2002,42, 493.
  7. I.J. Townshend and. Bissel AF.Sampling for Clinical Report Auditing,” Statistician 1987,36, 531–539.
  8. Bhatt A. The revamped Good Clinical Practice E6 (R3) guideline: Profound changes in principles and practice!. Perspectives in Clinical Research. 2023 Oct 1;14(4):167-71.
  9. Henderson L. Imaging Biomarker Network. Applied Clinical Trials. 2009;18(1):16.
  10. MRC Guidelines for Good Clinical Practice in Clinical Trials, 20 Park Crescent, London, W1N 4AL, United Kingdom, 1998.
Regular Issue Subscription Review Article
Volume 12
Issue 03
Received 07/08/2025
Accepted 20/08/2025
Published 26/08/2025
Publication Time 19 Days
348

Login


My IP

PlumX Metrics